跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 361 条关于
“SanBio”
全部
361
临床试验
165
药物
80
机构
43
资讯
73
去年
Stem Cell Therapy Restores Brain Activity in Rats After Stroke, SanBio's SB623 Shows Promise
去年
TBI Therapeutics Advance Through Clinical Trials: SanBio's SB623 Receives Sakigake Designation
去年
Mixed Results for Cancer and Neurological Drugs, Regulatory Scrutiny Intensifies for PBMs
去年
AstraZeneca and Daiichi Sankyo Seek Accelerated Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
2年前
Merck and Daiichi Sankyo Form $22 Billion Alliance for Three Novel Antibody-Drug Conjugates
11个月前
AskBio to Present AAV Gene Therapy Advances at ESGCT 2025 Meeting
3个月前
From Ground Zero to Oncology Care: A Daiichi Sankyo Leader's Journey
7小时前
Hutchmed Reports Positive Phase III SANOVO Trial Results in Lung Cancer
去年
Daiichi Sankyo and AstraZeneca Launch Phase III Trials of Datopotamab Deruxtecan Combinations in Advanced NSCLC
去年
FDA Filing for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
第 1 页,共 8 页
上一页
下一页